MedTrace Logo

Safe and Timely Antithrombotic Removal (STAR) Registry

NCT05077124 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2025-07-16

No results posted yet for this study

Summary

This registry will capture real-world clinical use patterns and associated clinical outcomes with the use of CytoSorb for the removal of antithrombotic agents.

Conditions

  • Hemorrhage, Surgical
  • Hemorrhage Postoperative
  • Blood Loss, Surgical
  • Blood Loss, Postoperative

Interventions

DEVICE

CytoSorb

Sorbent hemoperfusion system

Sponsors & Collaborators

  • CytoSorbents, Inc

    lead INDUSTRY

Principal Investigators

  • Michael Schmoeckel, Prof, MD · LMU Klinikum Großhadern

  • Robert Storey, Prof, BSc · University of Sheffield

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2025-09-30
Completion
2025-09-30

Countries

  • Austria
  • Belgium
  • Germany
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05077124 on ClinicalTrials.gov